RESEARCH QUESTION Does aerobic exercise have an effect on physiological fatigue, dyspnea, weight and body composition in HIV-infected adults?
THE STUDY DESIGN Randomized, wait-listed, controlled trial STUDY SETTING Infectious Disease Clinic and an associated AIDS Clinical Trials Unit at a large mid-western, academic medical center as well as from local service and social groups. Ethics approval obtained. Subjects signed the approved consent form.
PARTICIPANTS

Included:
HIV-1 infected adults; stable antiretroviral therapy Excluded:
No intake of anabolic steroids; growth hormone or appetite stimulants; could not have had an AIDS-defining illness, fever, active wasting or weight <85% of their ideal body weight; pregnant women
INTERVENTIONS
Intervention Group:
Ongoing aerobic exercise-training program 3 times a week for 12 weeks Control:
Subjects were contacted every other week by telephone or during a clinic visit. At the end of the first 12 weeks of participation, subjects were enrolled in the exercise protocol and exercised to week 24. 
OUTCOMES
DETECTION BIAS: Moderate
Participants and provider were unblind. All members of the GXT team testing team, except the principal investigator, were blinded to the subject's group assignment. Subjects completed questionnaires, had body weight, skinfold thickness and circumferences measured, had blood drawn and had to complete a 4-day food-use diary. FEV 1 was measured during a routine pulmonary function test. Height and weight were measured on a standard balance beam scale with a rigid vertical height rod. 
ADVERSE EVENTS
No adverse events were reported.
COMMENTS
Depending on how you look at the outcomes, aerobic exercise has a significant effect on some of them. When change in mean scores per group (pre and post) is compared, aerobic exercise decreases physiological fatigue, weight and body composition in HIV-infected adults but has no effect on dyspnea. When weighted mean difference (post only) is compared, aerobic exercise has a significant effect on physiological fatigue and triceps, central and peripheral skinfolds and VO 2 max as well as CD4+ cell count.
